Cargando…
Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study
BACKGROUND: Adherence is a necessary part of successful antiretroviral treatment (ART). We assessed risk factors for incomplete adherence among a cohort of HIV-infected women initiating ART and examined associations between adherence and virologic response to ART. METHODS: A secondary data analysis...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046911/ https://www.ncbi.nlm.nih.gov/pubmed/21303548 http://dx.doi.org/10.1186/1471-2458-11-88 |
_version_ | 1782198999648829440 |
---|---|
author | El-Khatib, Ziad Ekstrom, Anna Mia Coovadia, Ashraf Abrams, Elaine J Petzold, Max Katzenstein, David Morris, Lynn Kuhn, Louise |
author_facet | El-Khatib, Ziad Ekstrom, Anna Mia Coovadia, Ashraf Abrams, Elaine J Petzold, Max Katzenstein, David Morris, Lynn Kuhn, Louise |
author_sort | El-Khatib, Ziad |
collection | PubMed |
description | BACKGROUND: Adherence is a necessary part of successful antiretroviral treatment (ART). We assessed risk factors for incomplete adherence among a cohort of HIV-infected women initiating ART and examined associations between adherence and virologic response to ART. METHODS: A secondary data analysis was conducted on a cohort of 154 women initiating non-nucleoside reverse transcriptase inhibitor (NNRTI)-based ART at a single site in Johannesburg, South Africa. Ninety women had been enrolled in a prevention of mother-to-child transmission (pMTCT) program and were exposed to single-dose nevirapine (sdNVP) >18 months earlier. Women were interviewed pre-treatment and clinical, virologic and adherence data were collected during follow-up to 24 weeks. Incomplete adherence to ART was defined as returning >5% of medications, estimated by pill counts at scheduled visits. Multivariable logistic regression analysis and unadjusted odds ratio (95%CI) were performed, using STATA/SE (ver 10.1). RESULTS: About half of the women (53%) were <30 years of age, 63% had <11 years of schooling, 69% were unemployed and 37% lived in a shack. Seven percent of women had a viral load >400 copies/ml at 24 weeks and 37% had incomplete adherence at one or more visits. Incomplete adherence was associated with less education (p = 0.01) and lack of financial support from a partner (p = 0.02) after adjustment for confounders. Only when adherence levels dropped below 80% was there a significant association with viremia in the group overall (p = 0.02) although adherence <95% was associated with viremia in the sdNVP-exposed group (p = 0.03). The main reasons for incomplete adherence were being away from home, busy with other things and forgetting to take their medication. CONCLUSION: Virologic response to NNRTI-treatment in the cohort was excellent. However, women who received sdNVP were at greater risk of virologic failure when adherence was <95%. Women exposed to sdNVP, and those with less education and less social support may benefit from additional adherence counseling to ensure the long-term success of ART. More than 80% adherence may be sufficient to maintain virologic suppression on NNRTI-based regimens in the short-term, however complete adherence should be encouraged. |
format | Text |
id | pubmed-3046911 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30469112011-03-02 Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study El-Khatib, Ziad Ekstrom, Anna Mia Coovadia, Ashraf Abrams, Elaine J Petzold, Max Katzenstein, David Morris, Lynn Kuhn, Louise BMC Public Health Research Article BACKGROUND: Adherence is a necessary part of successful antiretroviral treatment (ART). We assessed risk factors for incomplete adherence among a cohort of HIV-infected women initiating ART and examined associations between adherence and virologic response to ART. METHODS: A secondary data analysis was conducted on a cohort of 154 women initiating non-nucleoside reverse transcriptase inhibitor (NNRTI)-based ART at a single site in Johannesburg, South Africa. Ninety women had been enrolled in a prevention of mother-to-child transmission (pMTCT) program and were exposed to single-dose nevirapine (sdNVP) >18 months earlier. Women were interviewed pre-treatment and clinical, virologic and adherence data were collected during follow-up to 24 weeks. Incomplete adherence to ART was defined as returning >5% of medications, estimated by pill counts at scheduled visits. Multivariable logistic regression analysis and unadjusted odds ratio (95%CI) were performed, using STATA/SE (ver 10.1). RESULTS: About half of the women (53%) were <30 years of age, 63% had <11 years of schooling, 69% were unemployed and 37% lived in a shack. Seven percent of women had a viral load >400 copies/ml at 24 weeks and 37% had incomplete adherence at one or more visits. Incomplete adherence was associated with less education (p = 0.01) and lack of financial support from a partner (p = 0.02) after adjustment for confounders. Only when adherence levels dropped below 80% was there a significant association with viremia in the group overall (p = 0.02) although adherence <95% was associated with viremia in the sdNVP-exposed group (p = 0.03). The main reasons for incomplete adherence were being away from home, busy with other things and forgetting to take their medication. CONCLUSION: Virologic response to NNRTI-treatment in the cohort was excellent. However, women who received sdNVP were at greater risk of virologic failure when adherence was <95%. Women exposed to sdNVP, and those with less education and less social support may benefit from additional adherence counseling to ensure the long-term success of ART. More than 80% adherence may be sufficient to maintain virologic suppression on NNRTI-based regimens in the short-term, however complete adherence should be encouraged. BioMed Central 2011-02-08 /pmc/articles/PMC3046911/ /pubmed/21303548 http://dx.doi.org/10.1186/1471-2458-11-88 Text en Copyright ©2011 El-Khatib et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article El-Khatib, Ziad Ekstrom, Anna Mia Coovadia, Ashraf Abrams, Elaine J Petzold, Max Katzenstein, David Morris, Lynn Kuhn, Louise Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study |
title | Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study |
title_full | Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study |
title_fullStr | Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study |
title_full_unstemmed | Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study |
title_short | Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study |
title_sort | adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in johannesburg, south africa - a prospective cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046911/ https://www.ncbi.nlm.nih.gov/pubmed/21303548 http://dx.doi.org/10.1186/1471-2458-11-88 |
work_keys_str_mv | AT elkhatibziad adherenceandvirologicsuppressionduringthefirst24weeksonantiretroviraltherapyamongwomeninjohannesburgsouthafricaaprospectivecohortstudy AT ekstromannamia adherenceandvirologicsuppressionduringthefirst24weeksonantiretroviraltherapyamongwomeninjohannesburgsouthafricaaprospectivecohortstudy AT coovadiaashraf adherenceandvirologicsuppressionduringthefirst24weeksonantiretroviraltherapyamongwomeninjohannesburgsouthafricaaprospectivecohortstudy AT abramselainej adherenceandvirologicsuppressionduringthefirst24weeksonantiretroviraltherapyamongwomeninjohannesburgsouthafricaaprospectivecohortstudy AT petzoldmax adherenceandvirologicsuppressionduringthefirst24weeksonantiretroviraltherapyamongwomeninjohannesburgsouthafricaaprospectivecohortstudy AT katzensteindavid adherenceandvirologicsuppressionduringthefirst24weeksonantiretroviraltherapyamongwomeninjohannesburgsouthafricaaprospectivecohortstudy AT morrislynn adherenceandvirologicsuppressionduringthefirst24weeksonantiretroviraltherapyamongwomeninjohannesburgsouthafricaaprospectivecohortstudy AT kuhnlouise adherenceandvirologicsuppressionduringthefirst24weeksonantiretroviraltherapyamongwomeninjohannesburgsouthafricaaprospectivecohortstudy |